Multiple endocrine neoplasia type II and familial medullary thyroid carcinoma. Impact of genetic screening on management.
The identification of ret protooncogene mutations in MEN-II and Hirschsprung disease has not only improved the clinical management of these genetic conditions but has also provided important information regarding mechanisms of transformation and neural crest development. An indication of how neural-crest cells migrate during embryonic life and the key processes involved in their differentiation now seems within reach. The continued pace of scientific discovery suggests that our understanding of and ability to prevent or treat hereditary and sporadic forms of MTC will continue to improve.
Gagel
R F
RF
University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
D018276:Carcinoma, Medullary / Q000235:genetics* / Q000628:therapy; D005820:Genetic Testing; D006801:Humans; D018813:Multiple Endocrine Neoplasia Type 2a / Q000235:genetics* / Q000628:therapy; D018814:Multiple Endocrine Neoplasia Type 2b / Q000235:genetics* / Q000628:therapy; D009154:Mutation; D010673:Pheochromocytoma / Q000235:genetics; D011519:Proto-Oncogenes; D013964:Thyroid Neoplasms / Q000235:genetics* / Q000628:therapy